David Shaw’s Immunomedics Inc IMMU Stock Holding History

David Shaw’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-93,200	Closed	-$3.3M	–	4332
2020 Q2	$3.3M	Buy	+93,200	New	+$2.72M	﹤0.01%	2003
2019 Q1	–	Sell	-60,000	Closed	-$856K	–	4057
2018 Q4	$856K	Hold	60,000	–	–	﹤0.01%	2762
2018 Q3	$1.25M	Hold	60,000	–	–	﹤0.01%	2535
2018 Q2	$1.42M	Hold	60,000	–	–	﹤0.01%	2466
2018 Q1	$877K	Hold	60,000	–	–	﹤0.01%	2579
2017 Q4	$970K	Buy	+60,000	New	+$708K	﹤0.01%	2592

David Shaw's IMMU Position: Q4 2020 in Review

David Shaw sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,514,427 shares — an estimated $129M sold.

David Shaw first reported a position in IMMU in Q1 2014 and held it in 21 quarters. The position peaked at $129M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

David Shaw reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
David Shaw sold 1,514,427 Immunomedics Inc shares in Q4 2020, an estimated $129M.
David Shaw first reported a position in Immunomedics Inc in Q1 2014 and held it in 21 quarters.
David Shaw's Immunomedics Inc position peaked at $129M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on D.E. Shaw & Co's 13F filing for Q4 2020, filed 16 Feb 2021.